Tandem Diabetes Stock Target Price and Analyst Consensus
| TNDM Stock | USD 30.93 0.82 2.58% |
The current analyst and expert consensus on Tandem Diabetes is Buy with 7 hold recommendations. The current projected Tandem Diabetes target price consensus is 39.33 with 16 analyst opinions. One of the most common ways Tandem Diabetes Care analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Tandem Diabetes vendors, executives, and/or customers. Tandem Diabetes recommendation module provides expert sentiment on the projected Tandem Diabetes Care target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Tandem Diabetes to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 35.79 | Highest Forecast 43.66 | Target Price 39.33 |
Tandem |
It's important to approach Tandem Diabetes' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Tandem Diabetes price targets
Tandem Diabetes' stock target price is an estimate of its future price, usually made by analysts. Using Tandem Diabetes' target price to determine if it is a suitable investment can be done through the following steps:- Look at Tandem Diabetes' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Tandem Diabetes' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Tandem Diabetes Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Tandem Diabetes is a key component of Tandem Diabetes valuation and have some predictive power on the future returns of a Tandem Diabetes.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tandem Diabetes' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Hedge Favorites Invested over 70 shares | |
 | Manufacturing Invested over 40 shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Investor Favorites Invested few shares | |
 | Momentum Invested over 200 shares | |
 | Warren Buffett Holdings Invested few shares | |
Check out Macroaxis Advice on Tandem Diabetes to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Tandem Diabetes Care information on this page should be used as a complementary analysis to other Tandem Diabetes' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Tandem Stock analysis
When running Tandem Diabetes' price analysis, check to measure Tandem Diabetes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tandem Diabetes is operating at the current time. Most of Tandem Diabetes' value examination focuses on studying past and present price action to predict the probability of Tandem Diabetes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tandem Diabetes' price. Additionally, you may evaluate how the addition of Tandem Diabetes to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
The data published in Tandem Diabetes' official financial statements usually reflect Tandem Diabetes' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Tandem Diabetes Care. For example, before you start analyzing numbers published by Tandem accountants, it's critical to develop an understanding of what Tandem Diabetes' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Tandem Diabetes' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tandem Diabetes' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Tandem Diabetes' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tandem Diabetes Care. Please utilize our Beneish M Score to check the likelihood of Tandem Diabetes' management manipulating its earnings.